The Organizing Committee of the conference invites you to submit an abstract and have an opportunity to share your work with local, regional, and international experts in the field of Diabetes and Endocrinology.
Abstract Submission requirement
-
Topics:- The abstract could cover audits, case reports, service development, clinical or basic research in the field of diabetes, endocrinology and metabolism.
-
Format:- All the fields should be filled as appropriate.
-
Authorship:- The number of authors on the abstract is limited to fifteen (15). Authors may use a maximum of two names for identifications (First name, Last name).
-
Word count:- Abstracts are limited to 300 words.
-
Tables/Figures :- Either 1 table or 1 figure could be uploaded. The table or figures should be well formatted and suitable for publication.
-
Abstract Body:- Make abstracts as informative as possible. Actual data should be summarized. It is inadequate to state "the results will be discussed" or "the data will be presented." Abstracts must be written in English with accurate grammar and spelling suitable for publication.
-
Review process:- The scientific committee with review all the abstracts submitted and the first author will be informed about the committee decision.
-
Submission: Abstract submission is closed
-
Presentation:- Accepted abstracts are expected to present their studies in a poster format throughout the two days of conference. Eight Abstracts will be selected for oral presentations and the remaining accepted abstracts will be poster presentations. Abstracts will be published as a supplement in a peer review journal.
-
Posters:- Abstracts accepted for poster presentations must be printed in
A0 portrait format
-
Registration:- For each accepted abstract, a presenting author must be identified and registered into the conference. Please note that we do not offer free registration for authors.
-
For more Enquiries: Please contact Dr. Mohamed Bashir at (MBashir@hamad.qa)
DEADLINE: - THE DEADLINE FOR SUBMISSION IS THE MIDNIGHT OF 5th of April 2024.